FDA Investigator: Amy A. Devlin
- Amy A. Devlin first started conducting FDA inspections in 2018, with the last inspection in 2020. Over that time, Amy A. Devlin has conducted 5 inspections at 3 companies across 3 sites.
Get Amy Devlin's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 GlaxoSmithKline dba Human Genome Sciences Inc, Rockville | 2020
Out-of-stock
Amy A. Devlin
Human Drug Form 483
FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC, Andover | 2019
Out-of-stock
Amy A. Devlin
Human Drug Form 483
FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2019
Out-of-stock
Amy A. Devlin
Human Drug Form 483
FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2019
Out-of-stock
Amy A. Devlin
Human Drug Form 483
FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2018
Out-of-stock
Amy A. Devlin
Human Drug Form 483